Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples